Has Jason Lang, MD received payments from drug or device companies?

Yes. Drug and device makers reported $3,117 in general payments to Jason Lang, MD across 45 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Jason Lang, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Jason Lang, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Jason Lang, MD

Orthopaedic Surgery · Bangor, MENPI 1326006347

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,994 of the $3,117 with a category attached, or 64.0%. Zimmer Biomet accounts for 61.5% of it on its own, with 13 other manufacturers making up the rest. 2025 is the largest year on record at $2,316, more than ten times the $176 reported in 2019.

$3,117in general payments, 2019–2025

Across 45 payments — averaging $69.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Zimmer Biomet$2K
Smith+Nephew$616
Molnlycke Health Care US, LLC$177
Arteriocyte Medical Systems, Inc.$139
Kairos Surgical Inc$81
Stryker$46
plus $142 from 8 others

$545,847in research payments, 2019–2025

Across 28 payments — averaging $19,495 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Roche Diagnostics Operations, Inc.$520K
Phadia US Inc.$25K
Sanofi US Services Inc.$920

What the payments were for

Travel & lodging$91629%
Food & beverage$1,99464%
Education$2077%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Zimmer Biomet	18	$1,916
Smith+Nephew	14	$616
Molnlycke Health Care US, LLC	1	$177
Arteriocyte Medical Systems, Inc.	1	$139
Kairos Surgical Inc	1	$81
Stryker	1	$46
Inari Medical, Inc.	2	$45
Abbott	1	$20
Endo Pharmaceuticals Inc.	1	$14
Heraeus Medical, LLC.	1	$14
Innocoll Pharmaceuticals Limited	1	$14
Mallinckrodt Enterprises LLC	1	$13
Pacira Pharmaceuticals Incorporated	1	$12
Kinex Medical Company LLC	1	$10

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,117 in reported general payments places this provider in the 55th percentile of 111 orthopaedic surgery providers in Maine.

See all orthopaedic surgery providers in Maine →

Medicare billing

Part B allowed, 2024

$524,035

Medicare patients

730

Services billed

5,203

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Amoxicillin	368	$804
Celecoxib	16	$509
Clindamycin Hcl	62	$288
Oxycodone Hcl	57	$267
Gabapentin	38	$165
Methocarbamol	21	$108
Tramadol Hcl	33	$94
Ondansetron OdtOndansetron	14	$83
Meloxicam	23	$37
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav	12	$33

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Bangor

Antonios TsismenakisBangor$37K
Jacob BrooksBangor$15K
Jessica AronowitzBangor$11K
Carmen CrofootBangor$3K
George BabikianFalmouth$446K
Nicholas ColacchioFalmouth$439K
Adam RanaFalmouth$330K
John HerzogFalmouth$258K
Matthew CamusoPortland$120K
Ian DickeyFarmington$75K

See the full list for Maine →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →